Can Centene Sustain Its Turnaround Amid Membership Pressure?

Centene Corporation (CNC) reported second-quarter 2026 adjusted earnings of $2.51 per share, a sharp reversal from a year-ago loss, as improved medical cost trends and operational execution drove the turnaround. The company reaffirmed full-year 2026 adjusted EPS guidance above $4.80.

CNC expects Medicaid membership to fall 8% to 9% in 2026, a headwind offset by profitability gains in its Marketplace and Medicare segments. Higher Medicaid reimbursement rates and cost-cutting initiatives are supporting the recovery despite the enrollment decline.

The quarter marks a critical test for CNC's ability to sustain margin improvement while navigating membership attrition in its largest business line. The reaffirmed guidance signals management confidence that rate increases and diversification into higher-margin products can compensate for volume pressure.